๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Pancreas Adenocarcinomas

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP NCT05268692Phase 2, Phase 31 site๐Ÿ“ Kochi Kochi University ยท Tests: GS, GnP VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel NCT06483555Phase 1, Phase 21 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Gemcitabine, Nab paclitaxel, Erlotinib, NALIRIFOX, Folfirinox A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC NCT06405490Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab Advanced Therapies for Liver Metastases NCT04622423n/a1 site๐Ÿ“ Milan IRCCS San Raffaele 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance NCT07483983Phase 27 sites๐Ÿ“ Villejuif๐Ÿ“ Bordeaux๐Ÿ“ Dijon Gustave Roussy, Cancer Campus, Grand Paris ยท Tests: ASP3082 Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma NCT06229496Phase 13 sites๐Ÿ“ Chiayi City๐Ÿ“ Kaohsiung City๐Ÿ“ Taoyuan Chang Gung Memorial Hospital ยท Tests: Gemcitabine 800mg/m2 + Nab-paclitaxel 100mg/m2 + S-1 (dose according to BSA), Gemcitabine 800mg/m2 + Nab-paclitaxel 125โ€ฆ AB122 Platform Study NCT04999761Phase 19 sites๐Ÿ“ Aichi๐Ÿ“ Chiba๐Ÿ“ Ehime Taiho Pharmaceutical Co., Ltd. ยท Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas NCT06842303NA1 site๐Ÿ“ Vandล“uvre-lรจs-Nancy Central Hospital, Nancy, France ยท Tests: Magnetic resonance elastography (MRE)., High-resolution diffusion sequence in MRI A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers NCT07769502Phase 27 sites๐Ÿ“ Hattiesburg๐Ÿ“ Ramat Gan๐Ÿ“ Jerusalem AbbVie ยท Tests: Telisotuzumab Adizutecan, Gemcitabine, Nab-Paclitaxel PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma NCT07047807NA1 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: PDAC-PATHWAYS, Usual Care A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer NCT07429487NA1 site๐Ÿ“ Nice Centre Antoine Lacassagne ยท Tests: APA program PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) NCT06673017Phase 19 sites๐Ÿ“ Newport Beach๐Ÿ“ Miami๐Ÿ“ Detroit PanTher Therapeutics ยท Tests: PTM-101 A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites๐Ÿ“ Newport Beach๐Ÿ“ Stanford๐Ÿ“ Miami Eli Lilly and Company ยท Tests: LY4337713 Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals NCT06122896EARLY Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Screening Blood Tests, Endoscopic Ultrasound, Magnetic Resonance Imaging, Magnetic Resonance Cholangiopancreatography Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer NCT06782932Phase 1, Phase 21 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: AGEN2373, Balstilimab, Cyclophosphamide, GVAX, AGEN2373 (RP2D) DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer NCT06757244Phase 25 sites๐Ÿ“ Marseille๐Ÿ“ Nantes๐Ÿ“ Paris Hopital Foch ยท Tests: Dostarlimab, Vitamin D3 (Cholecalciferol), mFOLFIRINOX Treatment Regimen, LV5FU2 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT06895031Phase 21 site๐Ÿ“ Beijing Guangzhou JOYO Pharma Co., Ltd ยท Tests: JYP0015 Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) NCT05346536NA1 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Detection of circulating tumor cells expressing Axl: CTC-AXL(+) Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma. NCT07148830NA1 site๐Ÿ“ Minya Minia University ยท Tests: Total Mesopancreas Excision (TMpE) (as part of Pancreaticoduodenectomy) Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma NCT07491445Phase 382 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles Revolution Medicines, Inc. ยท Tests: daraxonrasib, gemcitabine, nab-paclitaxel ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort NCT07808164n/a2 sites๐Ÿ“ Hanoi๐Ÿ“ Ho Chi Minh City Tam Anh Research Institute ยท Tests: IHC analysis for ENPP1, cGAS, and FAP expression Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer NCT06958328Phase 3333 sites๐Ÿ“ Gilbert๐Ÿ“ Gilbert๐Ÿ“ Peoria NRG Oncology ยท Tests: Biopsy Procedure, Biospecimen Collection, Capecitabine, Computed Tomography, Dose-escalated Radiation Therapy A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites๐Ÿ“ Clovis๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Bristol-Myers Squibb ยท Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring NCT07700992n/a1 site๐Ÿ“ Milan Universitร  Vita-Salute San Raffaele ยท Tests: PANXEON Efficacy of Fistulotomy for Biliary Cannulation NCT04037007NA1 site๐Ÿ“ Mexico City Coordinaciรณn de Investigaciรณn en Salud, Mexico ยท Tests: Fistulotomy - High experienced., Fistulotomy - Low experienced., Conventional (guidewire) cannulation- High experiencedโ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy